Biao Hu

11PUBLICATIONS
18CO-AUTHORS
Cancer cell biologyNutrigenomics and personalised nutritionChemical engineering designHealth and ecological risk assessmentMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 10, 2026
Non-Canonical Wnt11 Signaling Regulates Pulmonary Fibrosis via Fibroblast and Alveolar Epithelial Type II Cell Crosstalk.

Francina Gonzalez De Los Santos, Akira Ando, Biao Hu

|Aug 31, 2025
Food insecurity impacts neuroblastoma pathogenesis in murine xenograft tumor models.

Keyonna Williams, Sahiti Chukkapalli, Biao Hu

|Jun 13, 2025
MD-4251: A First-in-Class Oral MDM2 Degrader Inducing Complete Tumor Regression with Single-Dose Administration.

Ranjan Kumar Acharyya, Liyue Huang, Angelo Aguilar

|Apr 08, 2025
Correction to "Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer".

Ranjan Kumar Acharyya, Rohan Kalyan Rej, Biao Hu

|Nov 25, 2024
Discovery of ERD-12310A as an Exceptionally Potent and Orally Efficacious PROTAC Degrader of Estrogen Receptor α (ERα).

Rohan Kalyan Rej, Biao Hu, Zhixiang Chen

|Nov 01, 2024
Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer.

Ranjan Kumar Acharyya, Rohan Kalyan Rej, Biao Hu

Pageof 2

Frequent Collaborators

7 joint publications

Shaomeng Wang

5 joint publications

Duxin Sun

4 joint publications

Rohan Kalyan Rej

4 joint publications

Ranjan Kumar Acharyya